FDA Reviewer Questions Results of Key Avandia Trial
FRIDAY, July 9 (HealthDay News) -- One step ahead of a planned
government review of the safety of Avandia, new doubts surfaced
Friday on a key trial that helped keep the blockbuster diabetes
drug on the market.